282 related articles for article (PubMed ID: 23811086)
1. Synthesis and biological evaluation of ursolic acid-triazolyl derivatives as potential anti-cancer agents.
Rashid S; Dar BA; Majeed R; Hamid A; Bhat BA
Eur J Med Chem; 2013 Aug; 66():238-45. PubMed ID: 23811086
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and screening of ursolic acid-benzylidine derivatives as potential anti-cancer agents.
Dar BA; Lone AM; Shah WA; Qurishi MA
Eur J Med Chem; 2016 Mar; 111():26-32. PubMed ID: 26854375
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and cytotoxicity of novel ursolic acid derivatives containing an acyl piperazine moiety.
Liu MC; Yang SJ; Jin LH; Hu DY; Xue W; Song BA; Yang S
Eur J Med Chem; 2012 Dec; 58():128-35. PubMed ID: 23124210
[TBL] [Abstract][Full Text] [Related]
4. Click chemistry inspired facile synthesis and bioevaluation of novel triazolyl analogs of Ludartin.
Lone SH; Bhat KA; Majeed R; Hamid A; Khuroo MA
Bioorg Med Chem Lett; 2014 Feb; 24(4):1047-51. PubMed ID: 24484897
[TBL] [Abstract][Full Text] [Related]
5. Novel hederagenin-triazolyl derivatives as potential anti-cancer agents.
Rodríguez-Hernández D; Demuner AJ; Barbosa LC; Heller L; Csuk R
Eur J Med Chem; 2016 Jun; 115():257-67. PubMed ID: 27017553
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antitumor activity studies of some new fused 1,2,4-triazole derivatives carrying 2,4-dichloro-5-fluorophenyl moiety.
Bhat KS; Poojary B; Prasad DJ; Naik P; Holla BS
Eur J Med Chem; 2009 Dec; 44(12):5066-70. PubMed ID: 19822384
[TBL] [Abstract][Full Text] [Related]
7. An efficient one-pot synthesis of heterocycle-fused 1,2,3-triazole derivatives as anti-cancer agents.
Yan SJ; Liu YJ; Chen YL; Liu L; Lin J
Bioorg Med Chem Lett; 2010 Sep; 20(17):5225-8. PubMed ID: 20655212
[TBL] [Abstract][Full Text] [Related]
8. New 5-substituted thiazolo[3,2-b][1,2,4]triazol-6-ones: synthesis and anticancer evaluation.
Lesyk R; Vladzimirska O; Holota S; Zaprutko L; Gzella A
Eur J Med Chem; 2007 May; 42(5):641-8. PubMed ID: 17303290
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological testing of 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxin analogues as antitumor agents.
Reddy PB; Paul DV; Agrawal SK; Saxena AK; Kumar HM; Qazi GN
Arch Pharm (Weinheim); 2008 Feb; 341(2):126-31. PubMed ID: 18214838
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, determination of the lipophilicity, anticancer and antimicrobial properties of some fused 1,2,4-triazole derivatives.
Sztanke K; Tuzimski T; Rzymowska J; Pasternak K; Kandefer-Szerszeń M
Eur J Med Chem; 2008 Feb; 43(2):404-19. PubMed ID: 17531354
[TBL] [Abstract][Full Text] [Related]
11. 6-(4'-Aryl-1',2',3'-triazolyl)-spirostan-3,5-diols and 6-(4'-Aryl-1',2',3'-triazolyl)-7-hydroxyspirosta-1,4-dien-3-ones: Synthesis and analysis of their cytotoxicity.
Mironov ME; Oleshko OS; Pokrovskii MA; Rybalova TV; Pechurov VK; Pokrovskii AG; Cheresis SV; Mishinov SV; Stupak VV; Shults EE
Steroids; 2019 Nov; 151():108460. PubMed ID: 31344410
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and in vitro evaluation of novel ursolic acid derivatives as potential anticancer agents.
Hua SX; Huang RZ; Ye MY; Pan YM; Yao GY; Zhang Y; Wang HS
Eur J Med Chem; 2015 May; 95():435-52. PubMed ID: 25841199
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of antitumour (1H-1,2,3-triazol-4-yl)-4-hydroxycyclohexa-2,5-dien-1-ones by copper-catalysed Huisgen cycloadditions.
McCarroll AJ; Matthews CS; Wells G; Bradshaw TD; Stevens MF
Org Biomol Chem; 2010 May; 8(9):2078-84. PubMed ID: 20401384
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxins as potential anticancer agents.
Reddy PB; Agrawal SK; Singh S; Bhat BA; Saxena AK; Kumar HM; Qazi GN
Chem Biodivers; 2008 Sep; 5(9):1792-802. PubMed ID: 18816530
[TBL] [Abstract][Full Text] [Related]
15. Azide-alkyne cycloaddition en route to novel 1H-1,2,3-triazole tethered isatin conjugates with in vitro cytotoxic evaluation.
Singh P; Sharma P; Anand A; Bedi PM; Kaur T; Saxena AK; Kumar V
Eur J Med Chem; 2012 Sep; 55():455-61. PubMed ID: 22818042
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of novel 1,2,3-triazole derivatives of coronopilin as anti-cancer compounds.
Khazir J; Hyder I; Gayatri JL; Prasad Yandrati L; Nalla N; Chasoo G; Mahajan A; Saxena AK; Alam MS; Qazi GN; Sampath Kumar HM
Eur J Med Chem; 2014 Jul; 82():255-62. PubMed ID: 24910974
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of 4-(1,2,3-triazol-1-yl)coumarin derivatives as potential antitumor agents.
Zhang W; Li Z; Zhou M; Wu F; Hou X; Luo H; Liu H; Han X; Yan G; Ding Z; Li R
Bioorg Med Chem Lett; 2014 Feb; 24(3):799-807. PubMed ID: 24418772
[TBL] [Abstract][Full Text] [Related]
18. A library of 1,2,3-triazole-substituted oleanolic acid derivatives as anticancer agents: design, synthesis, and biological evaluation.
Wei G; Luan W; Wang S; Cui S; Li F; Liu Y; Liu Y; Cheng M
Org Biomol Chem; 2015 Feb; 13(5):1507-14. PubMed ID: 25476168
[TBL] [Abstract][Full Text] [Related]
19. D-ring substituted 1,2,3-triazolyl 20-keto pregnenanes as potential anticancer agents: Synthesis and biological evaluation.
Banday AH; Shameem SA; Gupta BD; Kumar HM
Steroids; 2010 Dec; 75(12):801-4. PubMed ID: 20206643
[TBL] [Abstract][Full Text] [Related]
20. A convergent synthesis of novel alkyne-azide cycloaddition congeners of betulinic acid as potent cytotoxic agent.
Dangroo NA; Singh J; Rath SK; Gupta N; Qayum A; Singh S; Sangwan PL
Steroids; 2017 Jul; 123():1-12. PubMed ID: 28435038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]